Biotech News

Veradigm Extends Stockholder Rights Plan

Veradigm (MDRX)Veradigm2026-06-25 13:46 ESTCompany update

CHICAGO --(BUSINESS WIRE)--Feb. 2, 2026-- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to

Open original release

Related news

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-06-25 13:46 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-06-25 13:46 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

MDRXVeradigm2026-06-25 13:46 EST

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Provides Business and Strategy Update

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer

MDRXVeradigm2026-06-25 13:46 EST

Veradigm Survey: Independent Practices Rely on Technology to Stay Independent

View all latest news

Veradigm

Veradigm is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

MDRXVeradigm2026-06-26 12:47 EST

Veradigm Files 2023 and 2024 Form 10-K

MDRXVeradigm2026-06-26 12:47 EST

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

MDRXVeradigm2026-06-26 12:47 EST

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

MDRXVeradigm2026-06-26 12:47 EST

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

MDRXVeradigm2026-06-26 12:47 EST

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States